5 assets in Chronic Leukemia

Therapeutic assets addressing Chronic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Chronic Leukemia	Roswell Park Cancer Institute	P4	BB (68)
Busulfanum Chronic Leukemia	University of Rochester	P4	B (63)
Fludarabine Chronic Leukemia	Roswell Park Cancer Institute	P2	B (57)
Melphalan Chronic Leukemia	University of Rochester	N/A	D (30)